BioSpace News Archive

BiomX Inc., a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced that the Company will host a conference call and a live audio webcast on Monday, May 24, 2021, at 8:00 a.m. EDT, to report first quarter 2021 financial results and provide business updates.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need, announced that Alex Howarth has joined Madrigal as Chief Financial Officer.

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that Karen Zaderej, chairman, CEO, and president and Peter J. Mariani, executive vice president and CFO will present at two upcoming investor conferences.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference. The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on May 26, 2021, at 2:00 PM EDT.

Data update for ongoing ACTengine® IMA200 clinical trial seriesdemonstratedfirst anti-tumor activity in heavily pre-treated solid cancer patients during early phases of dose escalation

- Partnership between University of Pennsylvania Gene Therapy Program, James Wilson, M.D., Ph.D., Tachi Yamada, M.D., and Temasek - US$200 million financing commitment from Temasek to fund development of next-generation gene therapy companies with Penn’s Gene Therapy Program

Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing novel therapies for diseases related to chronic glucose imbalance, today announced the addition of Quan Dong Nguyen, MD, MSc, FAAO, FARVO to its Scientific Advisory Board.

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments.

Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. is pursuing, through its licensing arrangements, the development of a small molecule drug for the treatment of colon cancer.

Novamind Inc., a leading mental health company specialized in psychedelic medicine, has opened a new Novamind Client Care Center to manage the overwhelming demand for its treatments and to support its planned growth to eight clinics by September 2021.